Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 177

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Multiple Defects in Energy Metabolism in Alzheimers Disease

L. Ferreira, I., Resende, R., Ferreiro, E., C. Rego, A., F. Pereira, C. · 2010 · Current Drug Targets

Abstract

Alzheimers disease (AD) is the most common form of dementia in old age. Cognitive impairment in AD may be partially due to overall hypometabolism. Indeed, AD is characterized by an early region-specific decline in glucose utilization and by mitochondrial dysfunction, which have deleterious consequences for neurons through increased production of reactive oxygen species (ROS), ATP depletion and activation of cell death processes. In this article, we provide an overview of the alterations on energetic metabolism occurring in AD. First, we resume the evidences that link the ‘metabolic syndrome’ with increased risk for developing AD and revisit the major changes occurring on both extramitochondrial and mitochondrial metabolic pathways, as revealed by imaging studies and biochemical analysis of brain and peripheral samples obtained from AD patients. We also cover the recent findings on cellular and animal models that highlight mitochondrial dysfunction as a fundamental mechanism in AD pathogenesis. Recent evidence posits that mitochondrial abnormalities in this neurodegenerative disorder are associated with changes in mitochondrial dynamics and can be induced by amyloid-beta (Aβ) that progressively accumulates within this organelle, acting as a direct toxin. Furthermore, Aβ induces activation of glutamate N-methyl-D-aspartate receptors (NMDARs) and/or excessive release of calcium from endoplasmic reticulum (ER) that may underlie mitochondrial calcium dyshomeostasis thereby disturbing organelle functioning and, ultimately, damaging neurons. Throughout the review, we further discuss several therapeutic strategies aimed to restore neuronal metabolic function in cellular and animal models of AD, some of which have reached the stage of clinical trials. Keywords: Alzheimer's disease, glucose metabolism, mitochondria, glutamate receptors, endoplasmic reticulum, calcium, Reactive oxygen species, Clinical trials, Endoplasmic reticulumn, Neurodegenerative disease, Dementia, Neurons, Brain disorder, Senile plaques, Insulin, FDG-PET, Mild cognitive impairment, Apolipoprotein E, Glycolysis, Apoptosis, Antioxidants, Resveratrol, Memory, Magnetic Resonance Spectroscopy, TCA Cycle, Ketone bodies, Electron transport chain, MitoQ, Mito VitE, Mitoperoxidase, Fission, Fusion, Homeostasis, Cognitive deficits, Cross-talk, NMDAR

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2174/1389450111007011193

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 34 references

Cited by

See all 177

Metadata

Authors
L. Ferreira, I., Resende, R., Ferreiro, E., C. Rego, A., & F. Pereira, C.
Venue
Current Drug Targets
Published
2010-10-01
Volume
11
Issue
10
Pages
1193-1206
ISSN
1389-4501 (ISSN-L)
OpenAlex
W2150603758
Cited by
177
References
34
FWCI
11.22
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multiple Defects in Energy Metabolism in Alzheimers Disease. https://app.cochat.ai/papers/10.2174/1389450111007011193
The paper
L. Ferreira, I., Resende, R., Ferreiro, E., C. Rego, A., & F. Pereira, C. (2010). Multiple Defects in Energy Metabolism in Alzheimers Disease. Current Drug Targets. https://doi.org/10.2174/1389450111007011193

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.